Surveillance: Optimizing Performance to Meet Infection Prevention and ADE Compliance
Tina Moen, PharmD, Chief Clinical Officer, Clinicians, Thomson Reuters Healthcare. Surveillance and reporting of clinical data for Infection prevention (IP) and Adverse Drug Event (ADE) intervention can represent a significant […]